Standards for follow-up care of patients with breast cancer

Breast

Volumn 14, Issue 6, 2005, Pages 500-508

  Peppercorn, Jeffery ^a   Partridge, Ann ^a   Burstein, Harold J ^a   Winer, Eric P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Follow up; Therapy

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ARTICLE; BODY WEIGHT DISORDER; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISTRESS SYNDROME; FATIGUE; FOLLOW UP; FRACTURE; GENE MUTATION; HUMAN; LYMPHEDEMA; MAMMOGRAPHY; MASTALGIA; MENOPAUSAL SYNDROME; METASTASIS; NEUROPATHY; OSTEOPOROSIS; OVARY INSUFFICIENCY; PAGET NIPPLE DISEASE; PATIENT CARE; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL DISORDER; SEXUAL DYSFUNCTION; SIDE EFFECT; THROMBOEMBOLISM; UNITED STATES; WEIGHT GAIN;

EID: 28044465601     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.09.001     Document Type: Article

References (56)

1. A. Jemal T. Murray E. Ward et al. Cancer statistics, 2005 CA Cancer J Clin 55 2005 10-30
2. D.P. Winchester J.M. Jeske R.A. Goldschmidt The diagnosis and management of ductal carcinoma in-situ of the breast CA Cancer J Clin 50 2000 184-200
3. National Cancer Institute. Estimated number of persons alive in the US diagnosed with cancer by site. 2005.
4. P.P. Rosen S. Groshen Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years Surg Clin North Am 70 1990 937-962
5. S.R. Schell E.D. Montague W.J. Spanos Jr et al. Bilateral breast cancer in patients with initial stage I and II disease Cancer 50 1982 1191-1194
6. X. Gao S.G. Fisher B. Emami Risk of second primary cancer in the contralateral breast in women treated for early stage breast cancer: A population-based study Int J Radiat Oncol Biol Phys 56 2003 1038-1045
7. K. Metcalfe H.T. Lynch P. Ghadirian et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2004 2328-2335
8. G. Arpino V.J. Bardou G.M. Clark et al. Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome Breast Cancer Res 6 2004 R149-R156
9. D.B. Thomas D.L. Gao R.M. Ray et al. Randomized trial of breast self-examination in Shanghai: Final results J Natl Cancer Inst 94 2002 1445-1457
10. Smith T.J., Davidson N.E., Schapira D.V., et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17: 1080-2.
11. E. Warner D.B. Plewes K.A. Hill et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 2004 1317-1325
12. M. Kriege C.T. Brekelmans C. Boetes et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427-437
13. S. McDonald D. Saslow M.H. Alciati Performance and reporting of clinical breast examination: A review of the literature CA Cancer J Clin 54 2004 345-361
14. M. Rosselli Del Turco D. Palli A. Cariddi et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up JAMA 271 1994 1593-1597
15. GIVIO Investigators Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial JAMA 271 1994 1587-1592
16. N. Bjurstam L. Bjorneld J. Warwick et al. The Gothenburg breast screening trial Cancer 97 2003 2387-2396
17. L. Nystrom I. Andersson N. Bjurstam et al. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials Lancet 359 2002 909-919
18. E. Warner D. Plewes K. Hill P. Causer G. Deboer S. Narod et al. Effect of age and temporal patterns over 5 years in a magnetic resonance imaging (MRI)-based breast surveillance study for BRCA mutation carriers, ASCO J Clin Oncol 22 Suppl 2004 9500 [abstract]
19. J.M. Bedwinek J. Lee B. Fineberg et al. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer Cancer 47 1981 2232-2235
20. B.G. Haffty A. Hauser D.H. Choi et al. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence Cancer 100 2004 252-263
21. S. Galper E. Blood B. Gelman et al. Prognosis after local recurrence after conservative surgery and radiation for early stage breast cancer Int J Radiat Oncol Biol Phys 61 2005 348-357
22. D.J. Krauss L.L. Kestin C. Mitchell et al. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications Int J Radiat Oncol Biol Phys 60 2004 731-740
23. B. Fisher S. Anderson E.R. Fisher et al. Significance of ipsilateral breast tumour recurrence after lumpectomy Lancet 38 1991 327-331
24. G.H. De Bock J. Bonnema J. van der Hage et al. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early stage invasive breast cancer: A meta-analysis and systematic review J Clin Oncol 22 2004 4010-4018
25. I.F. Faneyte J.L. Peterse H. Van Tinteren et al. Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement Clin Cancer Res 10 2004 4457-4463
26. A.M. Neville R. Bettelheim R.D. Gelber et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group J Clin Oncol 10 1992 696-705
27. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women Lancet 339 1992 71-85
28. P.A. Clavien U. Laffer J. Torhost et al. Gastro-intestinal metastases as first clinical manifestation of the dissemination of a breast cancer Eur J Surg Oncol 16 1990 121-126
29. J.C. Bendell S.M. Domchek H.J. Burstein et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2003 2972-2977
30. J.J. James A.J. Evans S.E. Pinder et al. Bone metastases from breast carcinoma: Histopathological-radiological correlations and prognostic features Br J Cancer 89 2003 660-665
31. T. Saphner D.C. Tormey R. Gray Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 14 1996 2738-2746
32. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer Adopted on May 17, 1996 by the American Society of Clinical Oncology J Clin Oncol 14 1996 2843-2877
33. S. Braun K. Pantel P. Muller et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 2000 525-533
34. K. Pantel V. Muller M. Auer et al. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer Clin Cancer Res 9 2003 6326-6334
35. D.J. Slamon B. Leyland-Jones S. Shak et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783-792
36. J.M. Nabholtz H.J. Senn W.R. Bezwoda et al. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group J Clin Oncol 17 1999 1413-1424
37. P. Schrenk R. Rieger A. Shamiyeh et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 2000 608-614
38. P.R. Kelemen Comprehensive review of sentinel lymphadenectomy in breast cancer Clin Breast Cancer 1 2000 111-125 [discussion 126]
39. A.W. Silberman C. McVay J.S. Cohen et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer Ann Surg 240 2004 1-6
40. R.E. Mansel A. Goyal L. Fallowfield R.G. Newcombe on behalf of ALMANAC Trialists Group Sentinel node biopsy in breast cancer: The first results of the randomized multicenter ALMANAC Trial J Clin Oncol 22 Suppl 2004 506 [abstract]
41. F. Fehlauer S. Tribius U. Holler et al. Long-term radiation sequelae after breast-conserving therapy in women with early stage breast cancer: an observational study using the LENT-SOMA scoring system Int J Radiat Oncol Biol Phys 55 2003 651-658
42. C. Badger N. Preston K. Seers et al. Physical therapies for reducing and controlling lymphoedema of the limbs Cochrane Database Syst Rev 2004 CD003141
43. L. Kligman R.K. Wong M. Johnston et al. The treatment of lymphedema related to breast cancer: A systematic review and evidence summary Support Care Cancer 12 2004 421-431
44. N. Tchen H.G. Juffs F.P. Downie et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer J Clin Oncol 21 2003 4175-4183
45. T.J. Postma J.B. Vermorken A.J. Liefting et al. Paclitaxel-induced neuropathy Ann Oncol 6 1995 489-494
46. E.G. Levine J.M. Raczynski J.T. Carpenter Weight gain with breast cancer adjuvant treatment Cancer 67 1991 1954-1959
47. A.B. Kornblith J.E. Herndon 2nd R.B. Weiss et al. Long-term adjustment of survivors of early stage breast carcinoma, 20 years after adjuvant chemotherapy Cancer 98 2003 679-689
48. G. Chaplain C. Milan C. Sgro et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: A population-based study J Clin Oncol 18 2000 2836-2842
49. B. Ramaswamy C.L. Shapiro Osteopenia and osteoporosis in women with breast cancer Semin Oncol 30 2003 763-775
50. M. Zambetti A. Moliterni C. Materazzo et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation J Clin Oncol 19 2001 37-43
51. B. Fisher J.P. Costantino D.L. Wickerham et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371-1388
52. A. Howell J. Cuzick M. Baum et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 2005 60-62
53. B.E. Hillner J.N. Ingle R.T. Chlebowski et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer J Clin Oncol 21 2003 4042-4057
54. E. Grunfeld D. Mant P. Yudkin et al. Routine follow up of breast cancer in primary care: Randomised trial BMJ 313 1996 665-669
55. E. Grunfeld M. Levine J. Julian K. Pritchard D. Coyle D. Mirsky et al. A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care J Clin Oncol 22 Suppl 2004 665 [abstract]
56. C.C. Earle H.J. Burstein E.P. Winer et al. Quality of non-breast cancer health maintenance among elderly breast cancer survivors J Clin Oncol 21 2003 1447-1451